Marshall Teitelbaum
Child & Adolescent Psychiatry · Jupiter, FLNPI 1336241207
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,118, 2.6 times the $423 reported in 2019.
Across 159 payments — averaging $19.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$632
- Corium, LLC$481
- Supernus Pharmaceuticals, Inc.$429
- Collegium Pharmaceutical, Inc.$294
- Lundbeck LLC$238
- AbbVie$202
- plus $768 from 13 others
What the payments were for
- Food & beverage$3,044100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 33 | $632 |
| Corium, LLC | 23 | $481 |
| Supernus Pharmaceuticals, Inc. | 22 | $429 |
| Collegium Pharmaceutical, Inc. | 11 | $294 |
| Lundbeck LLC | 12 | $238 |
| AbbVie(2 entities) | 10 | $202 |
| Tris Pharma Inc | 11 | $195 |
| Shire North American Group Inc | 11 | $111 |
| Ironshore Pharmaceuticals Inc. | 5 | $85 |
| E.r. Squibb & Sons, L.L.C. | 2 | $49 |
| Noven Therapeutics, LLC | 2 | $49 |
| Sunovion Pharmaceuticals Inc. | 3 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Adlon Therapeutics L.p. | 3 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Johnson & Johnson | 2 | $35 |
| Vertical Pharmaceuticals, LLC | 2 | $32 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JORNAY PM$125
How this compares
$3,044 in reported general payments places this provider in the 80th percentile of 206 child & adolescent psychiatry providers in Florida.
See all child & adolescent psychiatry providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alprazolam OdtAlprazolam | 13 | $3,952 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 69 | $2,248 |
| Divalproex Sodium ErDivalproex Sodium | 28 | $2,044 |
| Duloxetine Hcl | 62 | $1,429 |
| Lurasidone Hcl | 25 | $1,000 |
| Fluoxetine Hcl | 16 | $916 |
| Bupropion XlBupropion Hcl | 35 | $909 |
| Prazosin Hcl | 15 | $748 |
| Risperidone | 13 | $729 |
| Lamotrigine | 55 | $718 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 14 | $589 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 29 | $494 |
| Buspirone Hcl | 21 | $478 |
| Alprazolam | 48 | $447 |
| Clonazepam | 39 | $441 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Jupiter
- Craig KuninsGulfport$265K
- Elias SarkisGainesville$169K
- Jeffrey AlvaroSt Petersburg$87K
- Rosa Negron MunozLakeland$39K
- Sean HoranMiami$17K
- Rachel AgustinesLargo$16K
- Carlos BorgeSarasota$15K
- Justin SpoonerPonte Vedra Beach$12K
- Bhaskar RajuOrlando$11K
- Americo PadillaMiami$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.